Methods and systems for point-of-care synthesis and administration of particle-based therapeutics

Patent metadata

Field	Value
Publication number	US-2025041220-A1
Application number	US-202218706889-A
Country	US
Kind code	A1
Filing date	Aug 18, 2022
Priority date	Nov 5, 2021
Publication date	Feb 6, 2025
Grant date	—

Abstract

The present disclosure is related to an apparatus and system for synthesizing and administering particle-based therapeutics at the point-of-care. The apparatus includes a first chamber for receiving a first solution including lipids in a first solvent, a second chamber for receiving a second solution including nucleic acids in a second solvent, a mixing channel in communication with the first chamber and the second chamber, and a delivery system in communication with the to the mixing channel. The first solution in the first chamber and the second solution in the second chamber can be introduced into the mixing channel. The particle-based delivery system form in the mixing channel and the nucleic acids adhere to the particles. The formulated particle-based therapeutics are passed through a delivery system to a subject for administration.

First claim

1 . An apparatus for point-of-care administration, the apparatus comprising:
a plurality of chambers comprising a first chamber and a second chamber; an actuator coupled to the first chamber and the second chamber; a mixing channel downstream the first chamber and the second chamber, wherein the first chamber and the second chamber are each in fluid communication with the mixing channel; and a delivery system downstream from the mixing channel, wherein the delivery system is in fluid communication with the mixing channel.

2 . The apparatus of claim 1 , wherein the apparatus further comprises:
a first channel connecting the first chamber to the mixing channel; and a second channel connecting the second chamber to the mixing channel; wherein the first channel and the second channel converge into a single feed channel to the mixing channel.

3 . (canceled)

4 . The apparatus of claim 1 , wherein the mixing channel comprises a micromixer.

5 . The apparatus of claim 1 , wherein the actuator is coupled to a system configured to apply a force to move the actuator, wherein the actuator is a piston.

6 . (canceled)

7 . The apparatus of claim 5 , wherein the system comprises:
a biased spring coupled to the piston; and an anchor coupled to the biased spring, wherein the anchor comprises a retaining pin, wherein removing the retaining pin from the anchor is configured to release the biased spring to actuate the piston in each chamber.

8 . The apparatus of claim 1 , further comprising a third chamber;
wherein each of the first chamber, the second chamber, and the third chamber comprise an outlet channel comprising a valve; wherein each of the outlet channels converge to the mixing channel; and wherein the valve is configured to allow fluids to flow from the first chamber, the second chamber, and the third chamber to the mixing channel.

9 . (canceled)

10 . (canceled)

11 . (canceled)

12 . The apparatus of claim 1 , further comprising a separation unit between from the mixing channel and the delivery system, wherein the delivery system is a hypodermic needle, a cannula, a catheter, or a microneedle array.

13 . (canceled)

14 . A system for point-of-care administration, the system comprising:
a first chamber for receiving a first solution comprising nucleic acids in a first solvent; a second chamber for receiving a second solution comprising lipids in a second solvent; a mixing channel downstream the first chamber and the second chamber for receiving the first solution and the second solution, wherein the mixing channel is in fluid communication with the first chamber and the second chamber for mixing the first solution and the second solution to produce a third solution comprising lipid encapsulated nucleic acids; and a delivery system downstream from the mixing channel, wherein the delivery system is in fluid communication with the mixing channel.

15 . The system of claim 14 , wherein the first solvent comprises a water-based solution or a pH-modified water-based solution, and wherein the second solvent comprises an alcohol.

16 . (canceled)

17 . (canceled)

18 . (canceled)

19 . The system of claim 14 , wherein the second chamber comprises one or more lipids, sterols, and surfactants.

20 . (canceled)

21 . The system of claim 14 , wherein each of the first chamber and the second chamber further comprise an actuator configured to force the first solution and the second solution to the mixing channel;
wherein the actuator is a piston; wherein the piston is coupled to a biased spring; and wherein the piston and biased spring are coupled to an anchor comprising a retaining pin, wherein removing the retaining pin is configured to release the biased spring to actuate the piston in each chamber.

22 . (canceled)

23 . (canceled)

24 . (canceled)

25 . The system of claim 14 , further comprising a third chamber comprising an aqueous solution;
wherein each of the first chamber, the second chamber, and the third chamber include an outlet channel comprising a valve; wherein each of the outlet channels converge to the mixing channel; and wherein the valve is configured to allow fluids to flow from the first chamber, the second chamber, and the third chamber to the mixing channel.

26 . (canceled)

27 . (canceled)

28 . (canceled)

29 . The system of claim 14 , further comprising a separation unit between from the mixing channel and the delivery system;
wherein the separation unit comprises a membrane; wherein the separation unit is configured to receive a dialysis solution; and wherein the separation unit is configured to flow the dialysis solution counter to the third solution.

30 . (canceled)

31 . (canceled)

32 . (canceled)

33 . A method for synthesizing and administering particle-based therapeutics, the method comprising:
providing an apparatus comprising:
a first chamber;
a second chamber proximal to the first chamber;
an actuator coupled to the first chamber and the second chamber;
a mixing channel downstream the first chamber and the second chamber, wherein the first chamber and the second chamber are each in fluid communication with the mixing channel; and
a delivery system downstream from the mixing channel, wherein the delivery system is in fluid communication with the mixing channel;
filling the first chamber with a first solution comprising nucleic acids in a first solvent; filling the second chamber with a second solution comprising lipids in a second solvent; applying a force to each of the first chamber and the second chamber to force the first solution and the second solution into the mixing channel; forming a third solution comprising lipid encapsulated nucleic acids in the mixing channel; and administering the lipid encapsulated nucleic acids through the delivery system.

34 . The method of claim 33 , wherein the step of forming and administering occur concurrently.

35 . The method of claim 33 , wherein the first solvent comprises a water-based solution and the second solvent comprises an alcohol.

36 . (canceled)

37 . (canceled)

38 . The method of claim 33 , wherein the actuator is a piston;
wherein the piston is coupled to a biased spring; wherein the piston and biased spring are coupled to an anchor comprising a retaining pin; and wherein the method further comprises removing the retaining pin to release the biased spring to actuate the piston in each chamber to force the first solution and the second solution to the mixing channel.

39 . (canceled)

40 . (canceled)

41 . (canceled)

42 . The method of claim 33 , further comprising a third chamber comprising an aqueous solution;
wherein each of the first chamber, the second chamber, and the third chamber include an outlet channel comprising a valve; and wherein each of the outlet channels converge to the mixing channel.

43 . (canceled)

44 . (canceled)

45 . The method of claim 42 , wherein the method further comprises actuating the valve to allow contents in the first c

Assignees

• Verily Life Sciences Llc

Inventors

• Audeh Mark
• Paoli Eric
• Steyn Jasper Lodewyk
• Hutchison Jaeden

Classifications

• B01D61/243

  Dialysis · CPC title

• A61M5/32

  Needles; Details of needles pertaining to their connection with syringe or hub (infusion needles A61M5/158); Accessories for bringing the needle into, or holding the needle on, the body {(A61M5/42, A61M5/46 take precedence; guide needles for catheters A61M25/065)}; Devices for protection of needles {(apparatus specially adapted for cleaning or sterilising needles A61M5/001)} · CPC title

• A61K31/7088

  Compounds having three or more nucleosides or nucleotides · CPC title

• B01F2101/22

  Mixing of ingredients for pharmaceutical or medical compositions · CPC title

• B01F23/45

  using flow mixing · CPC title